Clinical trial
Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
NCT00083070 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00083070 |
|---|---|
| Title | Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia |
| Official title | A Phase I Trial Of Temozolomide In Pediatric Patients With Refractory/Recurrent Leukemias |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | temozolomide |
| Enrollment | 16 |
| Start date | Mar 1, 2004 |
| Primary completion | Sep 1, 2004 |
| Completion | Jun 1, 2008 |
| First posted | May 17, 2004 |
| Last update posted | Feb 20, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: